These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1454 related articles for article (PubMed ID: 38965243)
1. Cancer stem cells: advances in knowledge and implications for cancer therapy. Chu X; Tian W; Ning J; Xiao G; Zhou Y; Wang Z; Zhai Z; Tanzhu G; Yang J; Zhou R Signal Transduct Target Ther; 2024 Jul; 9(1):170. PubMed ID: 38965243 [TBL] [Abstract][Full Text] [Related]
2. Targeting cancer stem cell pathways for cancer therapy. Yang L; Shi P; Zhao G; Xu J; Peng W; Zhang J; Zhang G; Wang X; Dong Z; Chen F; Cui H Signal Transduct Target Ther; 2020 Feb; 5(1):8. PubMed ID: 32296030 [TBL] [Abstract][Full Text] [Related]
3. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment. Islam F; Gopalan V; Smith RA; Lam AK Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525 [TBL] [Abstract][Full Text] [Related]
4. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C Cells; 2020 Aug; 9(8):. PubMed ID: 32823711 [TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells: a potential target for cancer therapy. Qiu H; Fang X; Luo Q; Ouyang G Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289 [TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic strategies for targeting liver cancer stem cells. Oishi N; Wang XW Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419 [TBL] [Abstract][Full Text] [Related]
8. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma. Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681 [TBL] [Abstract][Full Text] [Related]
9. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553 [TBL] [Abstract][Full Text] [Related]
10. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction. Alemohammad H; Asadzadeh Z; Motafakker Azad R; Hemmat N; Najafzadeh B; Vasefifar P; Najafi S; Baradaran B Life Sci; 2020 Nov; 260():118337. PubMed ID: 32841661 [TBL] [Abstract][Full Text] [Related]
11. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109 [TBL] [Abstract][Full Text] [Related]
12. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies. Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S Cells; 2019 Aug; 8(8):. PubMed ID: 31530793 [TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance. Makena MR; Ranjan A; Thirumala V; Reddy AP Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586 [TBL] [Abstract][Full Text] [Related]
14. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma. Das PK; Islam F; Lam AK Cells; 2020 Jun; 9(6):. PubMed ID: 32503256 [TBL] [Abstract][Full Text] [Related]
15. Stem cell programs in cancer initiation, progression, and therapy resistance. Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274 [TBL] [Abstract][Full Text] [Related]
16. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells. Silva VR; Santos LS; Dias RB; Quadros CA; Bezerra DP Cancer Commun (Lond); 2021 Dec; 41(12):1275-1313. PubMed ID: 34791817 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells (CSCs) in cancer progression and therapy. Najafi M; Farhood B; Mortezaee K J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375 [TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
19. Resistance to Cell Death and Its Modulation in Cancer Stem Cells. Safa AR Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches targeting cancer stem cells. Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]